Health Policy Monitor
Skip Navigation

Pandemic influenza A(H1N1) vaccine policy in Japan

Country: 
Japan
Partner Institute: 
Kinugasa Research Institute, Ritsumeikan University, Kyoto
Survey no: 
(16)2010
Author(s): 
Taro Tomizuka and Ryozo Matsuda
Health Policy Issues: 
Public Health, Arzneimittelpolitik
Current Process Stages
Idee Pilotprojekt Strategiepapier Gesetzgebung Umsetzung Evaluation Veränderung/Richtungswechsel
Implemented in this survey? nein nein ja ja ja nein nein

Abstract

Pandemic influenza A(H1N1) vaccination in Japan has been run as a project that the Japanese government has undertaken directly. The government has taken responsibilities to secure enough amount of the vaccine covering the whole population, to efficiently distribute the vaccine to the nation, and to guarantee expenses of harms caused by the vaccine, which manufacturers usually take. However the government has not recommended the pandemic vaccine based on the existing Vaccination Act.

Purpose of health policy or idea

 Suchhilfe

Characteristics of this policy

Political and economic background

Purpose and process analysis

Current Process Stages

Idee Pilotprojekt Strategiepapier Gesetzgebung Umsetzung Evaluation Veränderung/Richtungswechsel
Implemented in this survey? nein nein ja ja ja nein nein

Expected outcome

References

Author/s and/or contributors to this survey

Taro Tomizuka and Ryozo Matsuda

Empfohlene Zitierweise für diesen Online-Artikel:

Taro Tomizuka and Ryozo Matsuda. "Pandemic influenza A(H1N1) vaccine policy in Japan". Health Policy Monitor, April 2010. Available at http://www.hpm.org/survey/jp/a16/1